The Wake Forest NCORP (NCI Community Oncology Research Program) Research Base is one of seven research bases funded by the NCI to develop and implement cancer prevention and control research for the NCORP community oncology research network. We partner with NCORP Community and Minority Underserved Community Sites across the county to test new approaches to cancer care delivery and the treatment, prevention and detection of cancer-related symptoms. Our goal is to conduct practice-changing cancer research that will improve patient outcomes.
Wake Forest NCORP provides the opportunity for community physicians to participate in NCI-supported treatment and cancer control and prevention trials. These trials test new approaches to cancer care delivery and the treatment, prevention and detection of cancer-related symptom management and outcomes.
Our goal is to conduct practice-changing cancer prevention and control research that will improve patient outcomes. Our studies are designed to be easy to implement and manage. Almost without exception, we will provide drugs for the study at no cost to the patient and limit any follow up to that which is relevant to the study.
Our accrual year runs from March 1 through the following February 28.
The Wake Forest NCORP Research Base has now implemented a password-protected web program for accessing all protocol documents and resources. For login information, visit the Member Area below.
Open Protocol Summaries
- WF-1901 IMPACTS Internet-delivered Management of Pain Among Cancer Treatment Survivors
- WF-1801 Pilot Study of Ramipril for Preventing Radiation-Induced Cognitive Decline in Glioblastoma (GBM) Patients Receiving Brain Radiotherapy
- WF-1802 Influence of Primary Treatment for Prostate Cancer on Work Experience (PCW)
- WF-1804CD Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among Survivors (AH-HA)
- WF-1805CD Implementation and Effectiveness Trial of HN-STAR
- WF-1806 Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults with Colorectal Cancer: The M&M Study
2022 Annual Meeting
Dates: October 10 - 11, 2022
Location: In-Person or Virtual via WebEx
This continuing nursing education activity was approved by the North Carolina Nurses’ Association and accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. This education activity has been approved for a maximum of 14 education credits. Each participant should claim only those credits spent in the activity.